title: AMP-activated protein kinase deficiency reduces ozone-induced lung injury and oxidative stress in mice.
abstract: BACKGROUND
  Acute ozone exposure causes lung oxidative stress and inflammation leading to lung injury. At least one mechanism underlying the lung toxicity of ozone involves excessive production of reactive oxygen and nitrogen intermediates such as peroxynitrite. In addition and beyond its major prooxidant properties, peroxynitrite may nitrate tyrosine residues altering phosphorylation of many protein kinases involved in cell signalling. It was recently proposed that peroxynitrite activates 5'-AMP-activated kinase (AMPK), which regulates metabolic pathways and the response to cell stress. AMPK activation as a consequence of ozone exposure has not been previously evaluated. First, we tested whether acute ozone exposure in mice would impair alveolar fluid clearance, increase lung tissue peroxynitrite production and activate AMPK. Second, we tested whether loss of AMP-activated protein kinase alpha1 subunit in mouse would prevent enhanced oxidative stress and lung injury induced by ozone exposure.
  
  
  METHODS
  Control and AMPKα1 deficient mice were exposed to ozone at a concentration of 2.0 ppm for 3 h in glass cages. Evaluation was performed 24 h after ozone exposure. Alveolar fluid clearance (AFC) was evaluated using fluorescein isothiocyanate tagged albumin. Differential cell counts, total protein levels, cytokine concentrations, myeloperoxidase activity and markers of oxidative stress, i.e. malondialdehyde and peroxynitrite, were determined in bronchoalveolar lavage (BAL) and lung homogenates (LH). Levels of AMPK-Thr172 phosphorylation and basolateral membrane Na(+)-K(+)-ATPase abundance were determined by Western blot.
  
  
  RESULTS
  In control mice, ozone exposure induced lung inflammation as evidence by increased leukocyte count, protein concentration in BAL and myeloperoxidase activity, pro-inflammatory cytokine levels in LH. Increases in peroxynitrite levels (3 vs 4.4 nM, p = 0.02) and malondialdehyde concentrations (110 vs 230 μmole/g wet tissue) were detected in LH obtained from ozone-exposed control mice. Ozone exposure consistently increased phosphorylated AMPK-Thr172 to total AMPK ratio by 80% in control mice. Ozone exposure causes increases in AFC and basolateral membrane Na(+)-K(+)-ATPase abundance in control mice which did not occur in AMPKα1 deficient mice.
  
  
  CONCLUSIONS
  Our results collectively suggest that AMPK activation participates in ozone-induced increases in AFC, inflammation and oxidative stress. Further studies are needed to understand how the AMPK pathway may provide a novel approach for the prevention of ozone-induced lung injury.
authors: Univ Lille Nord de France, F-59 000 Lille, France.
authors: Sébastien
authors: S
authors: Hulo
authors: Hélène
authors: H
authors: Tiesset
authors: Steve
authors: S
authors: Lancel
authors: Jean Louis
authors: JL
authors: Edmé
authors: Benoit
authors: B
authors: Viollet
authors: Annie
authors: A
authors: Sobaszek
authors: Rémi
authors: R
authors: Nevière
references: Curr Opin Pulm Med. 2003 Mar;9(2):144-50
references: 12574695
references: Cell Physiol Biochem. 2010;25(1):63-70
references: 20054145
references: Intensive Care Med. 2007 Jul;33(7):1243-1251
references: 17530222
references: J Clin Invest. 1997 Jan 15;99(2):325-35
references: 9006001
references: Anal Biochem. 1979 Jun;95(2):351-8
references: 36810
references: Am J Physiol Lung Cell Mol Physiol. 2008 Sep;295(3):L497-504
references: 18586954
references: Mol Cell Biol. 2009 Jul;29(13):3455-64
references: 19380482
references: Stroke. 2007 Nov;38(11):2992-9
references: 17901380
references: Am J Respir Cell Mol Biol. 2004 Jul;31(1):69-77
references: 14975936
references: J Biol Chem. 2008 Jul 18;283(29):20186-97
references: 18474592
references: Acta Physiol (Oxf). 2009 May;196(1):37-53
references: 19239414
references: J Physiol. 2006 Jul 1;574(Pt 1):7-15
references: 16644800
references: J Appl Physiol (1985). 2000 Aug;89(2):672-9
references: 10926653
references: Am J Physiol. 1998 Apr;274(4):L475-84
references: 9575865
references: J Biol Chem. 2006 Mar 10;281(10):6366-75
references: 16407220
references: J Physiol. 2006 Jul 1;574(Pt 1):85-93
references: 16690704
references: Am J Respir Cell Mol Biol. 2004 May;30(5):720-8
references: 14607816
references: Am J Physiol Lung Cell Mol Physiol. 2005 Jun;288(6):L1099-109
references: 15681398
references: Pflugers Arch. 2009 Aug;458(4):713-21
references: 19333618
references: Physiol Rev. 2009 Jul;89(3):1025-78
references: 19584320
references: Adv Exp Med Biol. 2009;648:351-60
references: 19536499
references: J Cereb Blood Flow Metab. 2010 Mar;30(3):480-92
references: 20010958
references: Curr Opin Nephrol Hypertens. 2005 Sep;14(5):464-71
references: 16046906
references: PLoS One. 2010 Nov 05;5(11):e15420
references: 21079763
references: Front Biosci (Landmark Ed). 2009 Jan 01;14:19-44
references: 19273052
references: Cardiovasc Res. 2007 Jul 15;75(2):291-302
references: 17544386
references: Adv Exp Med Biol. 2001;500:183-90
references: 11764933
references: Front Biosci (Landmark Ed). 2009 Jan 01;14:4809-14
references: 19273391
references: J Biol Chem. 2005 May 27;280(21):20493-502
references: 15772080
references: J Am Coll Cardiol. 2004 Jun 16;43(12):2348-58
references: 15193704
references: Inhal Toxicol. 2010 Dec;22 Suppl 2:84-94
references: 20883109
references: Free Radic Biol Med. 1994 Feb;16(2):149-56
references: 8005510
references: Nat Rev Mol Cell Biol. 2007 Oct;8(10):774-85
references: 17712357
references: J Biol Chem. 2006 Jul 21;281(29):19892-8
references: 16636055
references: Toxicol Sci. 2009 Nov;112(1):4-16
references: 19656995
references: Physiol Rev. 2007 Jan;87(1):315-424
references: 17237348